Physician profile

Emily Mack

General Practice (Dentist) · Glendale, AZ

NPI 1932639648

$496.98

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$127.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $298.57 2019
Dentsply Sirona INC $101.11 2022-2023 Astra Tech Implant System
Align Technology, INC. $46.51 2023 Itero Element 5d, Touch Up, Invisalign
Orapharma, A Division of Bausch Health US, LLC $22.07 2021
Philips North America LLC $14.43 2023
Biohorizons Implant Systems INC. $14.29 2023 Biohorizons

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Emily Mack

$496.98

in general payments reported 2019-2025

Years
2019-2023
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/4028615/emily-mack

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.